Advaxis and Sellas Life Sciences Group, two companies that have pursued different ways of prompting the body’s immune system to fight cancer, are now hoping that combining their efforts will lead to a more precise treatment. The agreement between the companies calls for Princeton, NJ-based Advaxis (NASDAQ: ADXS) to license to Sellas its technology for […]
What Our Clients Say
[ssba_hide]
[testimonials category="Testimonial" random=true limit="1"]
Press Releases and Whitepapers
Industry News & Articles
- Sam Altman biographer Keach Hagey explains why the OpenAI CEO was ‘born for this moment’
- Day 4 of TechCrunch Sessions: AI Trivia Countdown — Flex your brain, score big on tickets
- Video game union announces first contract with Microsoft
- 4 days to go: TechCrunch Sessions: AI is almost in session
- Left-leaning influencers embrace Bluesky without abandoning X, Pew says
- NAACP calls on Memphis officials to halt operations at xAI’s ‘dirty data center’
- Meta plans to automate many of its product risk assessments
- Week in Review: Perplexity Labs wants to do your work
Sample Relationships
[logo-carousel id=relationships]
Notables
[logo-carousel id=notables]